Pharmacokinetic profiles of ceftazidime in cochlear perilymph, cerebrospinal fluid and plasma: a high-performance liquid chromatographic study.
A pharmacokinetic profile of the antibiotic ceftazidime was established for perilymph, cerbrospinal fluid (CSF) and plasma in 12 guinea pigs using the technique of high-performance liquid chromatography. The mean peak levels of 13.35 mg/l in perilymph and 140.54 mg/l in plasma were reached within the first hour after a single intravenous dose of 100 mg/kg. The CSF mean peak level of 5.36 mg/l, however, was not attained until 3 h after injection. The half-life was about 4 h in perilymph, more than 6 h in CSF and less than 2 h in plasma. Six hours following administration, the perilymph drug concentration remained higher than the plasma level. The study indicates that ceftazidime has excellent penetration into perilymph. It is concluded that ceftazidime should be a very useful agent in the treatment of bacterial labyrinthitis caused by susceptible organisms.
Sun
A H
AH
Department of Otolaryngology, University of Western Ontario, London, Canada.
Parnes
L S
LS
Freeman
D J
DJ
D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy; D002442:Ceftazidime / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics*; D002511:Cephalosporins / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics*; D002851:Chromatography, High Pressure Liquid; D006168:Guinea Pigs; D006207:Half-Life; D007275:Injections, Intravenous; D007762:Labyrinthitis / Q000188:drug therapy / Q000382:microbiology; D010498:Perilymph / Q000737:chemistry; D013997:Time Factors
D002511:Cephalosporins; D002442:Ceftazidime